Estrogen-serotonin interactions: Implications for affective regulation

Biological Psychiatry

Volumn 44, Issue 9, 1998, Pages 839-850

  Rubinow, David R ^a   Schmidt, Peter J ^a   Roca, Catherine A ^a  

^a NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

Author keywords

Estrogen; Mood; Reproductive endocrinology; Serotonin

Indexed keywords

(3 CHLOROPHENYL)PIPERAZINE; BUSPIRONE; DEXFENFLURAMINE; ESTROGEN; PROLACTIN; SEROTONIN; TRYPTOPHAN;

DEPRESSION; ESTROGEN THERAPY; FEMALE; HORMONAL REGULATION; HORMONE PROTEIN COMPLEX; HUMAN; HUMAN CELL; HUMAN TISSUE; MALE; MOOD; NEUROMODULATION; OVARIECTOMY; PREMENSTRUAL SYNDROME; PRIORITY JOURNAL; REVIEW; SEROTONIN RELEASE; SEX DIFFERENCE;

AFFECT; ANIMALS; DEPRESSIVE DISORDER, MAJOR; ESTROGENS; FEMALE; GENE EXPRESSION REGULATION; GONADAL STEROID HORMONES; HUMANS; MENOPAUSE; MENSTRUAL CYCLE; NEURAL PATHWAYS; PREMENSTRUAL SYNDROME; RECEPTORS, SEROTONIN; RECEPTORS, STEROID; SEROTONIN; SEX CHARACTERISTICS;

EID: 0032213937     PISSN: 00063223     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-3223(98)00162-0     Document Type: Review

References (137)

1. Agren H, Mefford IN, Rudorfer MV, Linnoila M, Potter WZ (1986): Interacting neurotransmitter systems. A non-experimental approach to the 5-HIAA-HVA correlation in human CSF. J Psychiatr Res 20:175-193.
2. Alves SE, Weiland NG, Hastings NB, Tanapat P, McEwen BS (1997): Estradiol regulation of 5-HT neurons in the dorsal raphe of the rat differs from the monkey: An analysis of tryptophan hydroxylase mRNA levels. In: Abstracts of the 27th Annual Meeting of the Society of Neuroscience. p 1222.
3. Anderson I.M., Parry-Billings M., Newsholme E.A., Fairburn C.G., Cowen P.J. Dieting reduces plasma tryptophan and alters brain 5-HT function in women. Psychol Med. 20:1990;785-791.
4. Arato M., Frecska E., Tekes K., MacCrimmon D.J. Serotonergic interhemispheric asymmetry: Gender difference in the orbital cortex. Acta Psychiatr Scand. 84:1991;110-111.
5. Arnold S.F., Klotz D.M., Collins B.M., Vonier P.M., Guillette L.J. Jr, McLachlan J.A. Synergistic activation of estrogen receptor with combinations of environmental chemicals. Science. 272:1996;1489-1492.
6. 3-H-imipramine binding in the frontal cortex of suicides. Psychiatry Res. 30:1989;125-135.
7. Ashby C.R. Jr, Carr L.A., Cook C.L., Steptoe M.M., Franks D.D. Alteration of platelet serotonergic mechanisms and monoamine oxidase activity in premenstrual syndrome. Biol Psychiatry. 24:1988;225-233.
8. Ashby C.R. Jr, Carr L.A., Cook C.L., Steptoe M.M., Franks D.D. Alteration of 5-HT uptake by plasma fractions in the premenstrual syndrome. J Neural Transm Gen Sect. 79:1990;41-50.
9. Auricchio F. Phosphorylation of steroid receptors. J Steroid Biochem. 32:1989;613-622.
10. Backstrom T., Sanders D., Leask R., Davidson D., Warner P., Bancroft J. Mood, sexuality, hormones, and the menstrual cycle: II. Hormone levels and their relationship to the premenstrual syndrome. Psychosom Med. 45:1983;503-507.
11. Bancroft J., Cook A. The neuroendocrine reponse to d-fenfluramine in women with premenstrual depression. J Affect Disord. 36:1995;57-64.
12. Bancroft J., Boyle H., Warner P., Fraser H.M. The use of an LHRH agonist, buserelin, in the long-term management of premenstrual syndromes. Clin Endocrinol. 27:1987;171-182.
13. Bancroft J., Cook A., Davidson D., Bennie J., Goodwin G. Blunting of neuroendocrine responses to infusion of L-tryptophan in women with perimenstrual mood change. Psychol Med. 21:1991;305-312.
14. Best N.R., Barlow D.H., Rees M.P., Cowen P.J. Lack of effect of oestradiol implant on platelet imipramine and 5-HT2 receptor binding in menopausal subjects. Psychopharmacology (Berl). 98:1989;561.
15. 1 receptors in brain. J Neurosci. 2:1982;199-205.
16. Biegon A., Segal M., Samuel D. Sex differences in behavioral and thermal responses to pargyline and tryptophan. Psychopharmacology (Berl). 61:1979;77-80.
17. Biegon A., Reches A., Snyder L., McEwen B.S. Serotonergic and noradrenergic receptors in the rat brain: Modulation by chronic exposure to ovarian hormones. Life Sci. 32:1983;2015-2021.
18. Bitran D., Hull E. Pharmacological analysis of male rat sexual behavior. Neurosci Biobehav Rev. 11:1987;365-389.
19. 2 receptor in the living human brain. Neurosci Lett. 204:1996;25-28.
20. Blanchard D.C., Shepherd J.K., Rodgers R.J., Blanchard R.J. Evidence for differential effects of 8-OH-DPAT on male and female rats in the anxiety/defense test battery. Psychopharmacology (Berl). 106:1992;531-539.
21. Bonson K.R., Johnson R.G., Fiorella D., Rabin R.A., Winter J.C. Serotonergic controls of androgen-induced dominance. Pharmacol Biochem Behav. 49:1994;313-322.
22. Borisova N.A., Proshlyakova E.V., Sapronova A.Y., Ugrumov M.V. Androgen-dependent sex differences in the hypothalamic serotoninergic system. Eur J Endocrinol. 134:1996;232-235.
23. Bucht G., Adolfsson R., Gottfries C.G., Roosa B.-E., Winblad B. Distribution of 5-hydroxytryptamine and 5-hydroxyindoleacetic acid in human brain in relation to age, drug influence, agonal status and circadian variation. J Neural Transm Gen Sect. 51:1981;185-203.
24. Butler R.N., Lewis M.I. Late-life depression: When and how to intervene. Geriatrics. 50:1995;44-55.
25. Carlsson M., Carlsson A. A regional study of sex differences in rat brain serotonin. Prog Neuropsychopharmacol Biol Psychiatry. 12:1988;53-61.
26. Carlsson M., Eriksson E. A central serotonin receptor agonist, 8-hydroxy-2-(di-n-propylamino) tetralin, has different effects on prolactin secretion in male and female rats. Acta Pharmacol Toxicol. 58:1986;297-302.
27. Carlsson M., Svensson K., Ericksson E., Carlsson A. Rat brain serotonin: Biochemical and functional evidence for a sex difference. J Neural Transm Gen Sect. 63:1985;297-313.
28. Casson P., Hahn P.M., VanVugt D.A., Reid R.L. Lasting response to ovariectomy in severe intractable premenstrual syndrome. Am J Obstet Gynecol. 162:1990;99-105.
29. Charney D.S., Woods S.W., Goodman W.K., Heninger G.R. Serotonin function in anxiety: II. Effects of the serotonin agonist MCPP in panic disorder patients and healthy subjects. Psychopharmacology (Berl). 92:1987;14-24.
30. Chouinard G., Steinberg S., Steiner W. Estrogen-progesterone combination: Another mood stabilizer? Am J Psychiatry. 144:1987;826.
31. Clarke W.P., Maayani S. Estrogen effects on 5-HT1A receptors in hippocampal membranes from ovariectomized rats: Functional and binding studies. Brain Res. 518:1990;287-291.
32. Clarke CH, Cunningham KA, Bland DA, Steinsland OS (1997): Sex hormone regulation of estrogen receptor (ERa and ERb) mRNA in female rat brain. In: Abstracts of the 27th Annual Meeting of the Society of Neuroscience. p 1501.
33. Cohen I.R., Wise P.M. Effects of estradiol on the diurnal rhythm of serotonin activity in microdissected brain areas of ovariectomized rats. Endocrinology. 122:1988;2619-2625.
34. Cone R.I., Davis G.A., Goy R.W. Effects of ovarian steroids on serotonin metabolism within grossly dissected and microdissected brain regions of the ovariectomized rat. Brain Res Bull. 7:1981;639-644.
35. 1A receptor sensitivity in major depression: A neuroendocrine study with buspirone. Br J Psychiatry. 164:1994;372-379.
36. Deakin J.F.W., Pennell I., Upadhyaya A.J., Lofthouse R. A neuroendocrine study of 5-HT function in depression: Evidence for biological mechanisms of endogenous and psychosocial causation. Psychopharmacology (Berl). 101:1990;85-92.
37. Delgado P.L., Charney D.S., Price L.H., Landis H., Heninger G.R. Neuroendocrine and behavioral effects of dietary tryptophan restriction in healthy subjects. Life Sci. 45:1989;2323-2332.
38. Diamond M.I., Miner J.N., Yoshinaga S.K., Yamamoto K.R. Transcription factor interactions: Selectors of positive or negative regulation from a single DNA element. Science. 249:1990;1266-1272.
39. Ditkoff E.C., Crary W.G., Cristo M., Lobo R.A. Estrogen improves psychological function in asymptomatic postmenopausal women. Obstet Gynecol. 78:1991;991-995.
40. Easterbrook C.C. Organo-therapeutics in mental diseases. Br Med J. 2:1900;813-823.
41. 1A agonists 8-OH-DPAT and gepirone. Methods Find Exp Clin Pharmacol. 16:1997;91-96.
42. Ellenbogen M.A., Young S.N., Dean P., Palmour R.M., Benkelfat C. Mood response to acute tryptophan depletion in healthy volunteers: Sex differences and temporal stability. Neuropsychopharmacology. 15:1996;465-474.
43. Enmark EP-HM, Grandien K., Lagercrantz S., et al. Human estrogen receptor β-gene structure, chromosomal localization, and expression pattern. J Clin Endocrinol Metab. 82:1997;4258-4265.
44. Eriksson E, Humble M (1990): Serotonin in psychiatric pathophysiology: A review of data from experimental and clinical research. In: Pohl R, Gershon S, editors. The Biological Basis of Psychiatric Treatment. Basel: Karger, pp 66-119.
45. Eriksson E., Hedberg M.A., Andersch B., Sundblad C. The serotonin reuptake inhibitor paroxetine is superior to the noradrenaline reuptake inhibitor maprotiline in the treatment of premenstrual syndrome. Neuropsychopharmacology. 12:1995;167-176.
46. Facchinetti F., Genazzani A.D., Martignoni E., Fioroni L., Nappi G., Genazzani A.R. Neuroendocrine changes in luteal function in patients with premenstrual syndrome. J Clin Endocrinol Metab. 76:1993;1123-1127.
47. Fischette C.T., Biegon A., McEwen B.S. Sex differences in serotonin 1 receptor binding in rat brain. Science. 222:1983;333-335.
48. Fischette C.T., Biegon A., McEwen B.S. Sex steroid modulation of the serotonin behavioral syndrome. Life Sci. 35:1984;1197-1206.
49. Fludder J.M., Tonge S.R. Variations in the concentrations of monoamines and their metabolites in eight regions of rat brain during the oestrous cycle: A basis for interactions between hormones and psychotrophic drugs. J Pharm Pharmacol. 27:1975;39P.
50. Gitlin M.J. Psychotropic medications and their effects on sexual function: Diagnosis, biology, and treatment approaches. J Clin Psychiatry. 55:1994;406-413.
51. Giulian D., Pohorecky L.A., McEwen B.S. Effects of gonadal steroids upon brain 5-hydroxytryptamine levels in the neonatal rat. Endocrinology. 93:1973;1329-1335.
52. Gonzalez M.I., Farabollini F., Albonetti E., Wilson C.A. Interactions between 5-hydroxytryptamine (5-HT) and testosterone in the control of sexual and nonsexual behaviour in male and female rats. Pharmacol Biochem Behav. 47:1994;591-601.
53. Goodman R.L. A quantitative analysis of the physiological role of estradiol and progesterone in the control of tonic and surge secretion of luteinizing hormone in the rat. Endocrinology. 102:1978;142-150.
54. Goodwin G.M., Murray C.L., Bancroft J. Oral d-fenfluramine and neuroendocrine challenge: Problems with the 30 mg dose in men. J Affect Disord. 30:1994;117-122.
55. Halbreich U., Endicott J., Goldstein S., Nee J. Premenstrual changes and changes in gonadal hormones. Acta Psychiatr Scand. 74:1986;576-586.
56. Halbreich U., Rojansky N., Palter S., Tworek H., Hissin P., Wang K. Estrogen augments serotonergic activity in postmenopausal women. Biol Psychiatry. 37:1995;434-441.
57. 1A receptor-dependent responses more in females. Eur J Pharmacol. 164:1989;435-443.
58. 1A agonist 8-OH-DPAT. J Neural Transm Gen Sect. 79:1990;93-102.
59. Jo D.-H., Abdallah M.A., Young J., Baulieu E.-E., Robel P. Pregnenolone, dehydroepiandrosterone, and their sulfate and fatty acid esters in the rat brain. Steroids. 54:1989;287-297.
60. Johnson J.H., Kitts C.S. Serotonergic mediation of a negative feedback effect of estrogen on luteinizing hormone release in ovariectomized rats. Endocrinology. 123:1988;2270-2275.
61. Jung-Testas I., Hu Z.Y., Baulieu E.E., Robel P. Steroid synthesis in rat brain cell cultures. J Steroid Biochem. 34:1989;511-519.
62. Kahn R.S., Wetzier S., Asnis G.M., Kling M.A., Suckow R.F., vanPraag H.M. Pituitary hormone response to metachlorophenylpiperazine in panic disorder and healthy control subjects. Psychiatry Res. 37:1991;25-34.
63. Kato R. Serotonin content of rat brain in relation to sex and age. J Neurochem. 5:1960;202-205.
64. Katzenellenbogen J.A., O'Malley B.W., Katzenellenbogen B.S. Tripartite steroid hormone receptor pharmacology: Interaction with multiple effector sites as a basis for the cell- and promoter-specific action of these hormones. Mol Endocrinol. 10:1996;119-131.
65. Keck PE Jr, Hudson JI, Dorsey CM, Campbell PI (1991): Effect of fluoxetine on sleep [letter to the editor]. Biol Psychiatry 29:618-625.
66. Kendall D.A., Stancel G.M., Enna S.J. Imipramine: Effect of ovarian steroids on modifications in serotonin receptor binding. Science. 211:1981;1183-1185.
67. Knorring L.V., Oreland L., Häggendal J., Magnusson T., Almay B., Johansson F. Relationship between platelet MAO activity and concentrations of 5-HIAA and HVA in cerebrospinal fluid in chronic pain patients. J Neural Transm Gen Sect. 66:1986;37-46.
68. Kueng W., Wirz-Justice A., Menze B., Chapuis-Arndt E. Regional brain variations of tryptophan, monoamines, monoamine oxidase activity, plasma free and total tryptophan during the estrous cycle of the rat. Neuroendocrinology. 21:1976;289-296.
69. Kuiper G.G.J.M., Enmark E., Pelto-Huikko M., Nilsson S., Gustafsson J.-A. Cloning of a novel estrogen receptor expressed in rat prostate and ovary. Proc Natl Acad Sci USA. 93:1996;5925-5930.
70. Lacoste V., Wirz-Justice A., Graw P., Puhringer W., Gastpar M. Intravenous L-5-hydroxytryptophan in normal subjects: An interdisciplinary precursor loading study. Part IV: Effects on body temperature and cardiovascular functions . Pharmakopsychiatr Neuropsychopharmakol. 9:1976;289-294.
71. 1A mediated responses in the dorsal raphe nucleus (DRN). Pharmacologist. 30:1988;A126-A128.
72. Lambert J.J., Belelli D., Hill-Venning C., Callachan H., Peters J.A. Neurosteroid modulation of native and recombinant GABAA receptors. Cell Mol Neurobiol. 16:1996;155-174.
73. Li X., Schwartz P.E., Rissman E.F. Distribution of estrogen receptor-b-like immunoreactivity in rat forebrain. Neuroendocrinology. 66:1997;63-67.
74. Linnoila M., Virkkunen M., George T., Higley D. Impulse control disorders. Int Clin Psychopharmacol. 8:1993;53-56.
75. Lippert T.H., Filshie M., Mück A.O., Seeger H., Zwirner M. Serotonin metabolite excretion after postmenopausal estradiol therapy. Maturitas. 24:1996;37-41.
76. Mani S.K., Allen J.M.C., Clark J.H., Blaustein J.D., O'Malley B.W. Convergent pathways for steroid hormone- and neurotransmitter-induced rat sexual behavior. Science. 265:1994;1246-1248.
77. 1A agonist, 8-OH-DPAT, on hypothalamic serotonin. Pharmacol Biochem Behav. 51:1995;807-813.
78. Maswood S, Truitt B, Caldarola-Pastuszka M, Uphouse L (1997): Diurnal changes in hypothalamic serotonin during the estrous cycle: Examination by microdialysis. In: Abstracts of the 27th Annual Meeting of the Society of Neuroscience. p 1222.
79. 1A) receptor activation. Life Sci. 48:1991;1627-1632.
80. 1A receptor agonists. Eur J Pharmacol. 200:1991;299-304.
81. McBride P.A., Tierney H., DeMeo M., Chen J.-S., Mann J.J. Effects of age and gender on CNS serotonergic responsivity in normal adults. Biol Psychiatry. 27:1990;1143-1155.
82. McQueen J.K., Wilson H., Dow R.C., Fink G. Oestradiol-17b increases serotonin transporter (SERT) binding sites and SERT mRNA expression in discrete regions of female rat brain. J Physiol. 495.P:1996;114P.
83. McQueen J.K., Wilson H., Fink G. Estradiol-17β increases serotonin transporter (SERT) mRNA levels and the density of SERT-binding sites in female rat brain. Mol Brain Res. 45:1997;13-23.
84. Meltzer H.Y., Maes M. Effects of buspirone on plasma prolactin and cortisol levels in major depressed and normal subjects. Biol Psychiatry. 35:1994;316-323.
85. Menkes D.B., Coates D.C., Fawcett J.P. Acute tryptophan depletion aggravates premenstrual syndrome. J Affect Disord. 32:1994;37-44.
86. Meyer M.-E., Gronemeyer H., Turcott B., Bocquel M.-T., Tasset D., Chambon P. Steroid hormone receptors compete for factors that mediate their enhancer function. Cell. 57:1989;433-442.
87. Mezrow G., Shoupe D., Spicer D., Lobo R., Leung B., Pike M. Depot leuprolide acetate with estrogen and progestin add-back for long-term treatment of premenstrual syndrome. Fertil Steril. 62:1994;932-937.
88. Mortola J.F., Girton L., Fischer U. Successful treatment of severe premenstrual syndrome by combined use of gonadotropin-releasing hormone agonist and estrogen/progestin. J Clin Endocrinol Metab. 71:1991;252A-252F.
89. Mosselman S., Polman J., Dijkema R. ERb Identification and characterization of a novel human estrogen receptor . FEBS Lett. 392:1996;49-53.
90. Mueck A.O., Seeger H., Kabpohl-Butz S., Teichmann A.T., Lippert T.H. Influence of norethisterone acetate and estradiol on the serotonin metabolism of postmenopausal women. Horm Metab Res. 29:1997;80-83.
91. Murphy D.L., Mueller E.W., Hill J.L., Tolliver T.J., Jacobsen F.M. Comparative anxiogenic, neuroendocrine, and other physiologic effects of m-chlorophenylpiperazine given intravenously or orally to healthy volunteers. Psychopharmacology (Berl). 98:1989;275-282.
92. Muse K.N., Cetel N.S., Futterman L.A., Yen S.S.C. The premenstrual syndrome: Effects of "medical ovariectomy" N Engl J Med. 311:1984;1345-1349.
93. Nishizawa S., Benkelfat C., Young S.N., et al. Differences between males and females in rates of serotonin synthesis in human brain. Proc Natl Acad Sci USA. 94:1997;5308-5313.
94. O'Keane V., O'Hanlon M., Webb M., Dinan T. d-Fenfluramine/prolactin response throughout the menstrual cycle: Evidence for an oestrogen-induced alteration. Clin Endocrinol. 34:1991;289-292.
95. Palego L., Marazziti D., Rossi A., et al. Apparent absence of aging and gender effects on serotonin 1A receptors in human neocortex and hippocampus. Brain Res. 758:1997;26-32.
96. Pecins-Thompson M., Brown N.A., Bethea C.L. Regulation of serotonin reuptake transporter mRNA expression by ovarian steroids in rhesus macaques. Mol Brain Res. 53:1998;120-129.
97. Pecins-Thompson M., Brown N.A., Kohama S.G., Bethea C.L. Ovarian steroid regulation of tryptophan hydroxylase mRNA expression in rhesus macaques. J Neurosci. 16:1996;7021-7029.
98. Pecins-Thompson M, Schutzer WE, Bethea CL (1996): Estrogen regulation of tryptophan hydroxylase (TPH), serotonin transporter (SERT) and norepinephrine transporter (NET) genes in nonhuman primates. In: Abstracts of the 35th Annual Meeting of the ACNP. p 87.
99. Pettersson K., Grandien K., Kuiper G.G.J.M., Gustafsson J.-A. Mouse estrogen receptor b forms estrogen response element-binding heterodimers with estrogen receptor a. Mol Endocrinol. 11:1997;1486-1496.
100. Rapkin A.J., Edelmuth E., Chang L.C., Reading A.E., McGuire M.T., Su T.P. Whole-blood serotonin in premenstrual syndrome. Obstet Gynecol. 70:1987;533-537.
101. Redei E., Freeman E.W. Daily plasma estradiol and progesterone levels over the menstrual cycle and their relation to premenstrual symptoms. Psychoneuroendocrinology. 20:1995;259-267.
102. Roca CA, Schmidt PJ, Danaceau MA, Greenberg B, Murphy DL, Rubinow DR (1996): Recurrence of symptoms in fluoxetine-treated PMS patients after metergoline administration. In: Abstracts of the 35th Annual Meeting of the ACNP. p 169.
103. Roca CA, Rosenstein DL, Schmidt PJ, et al (1997): Mechanism of efficacy of fluoxetine in premenstrual syndrome. In: Abstracts of the 51st Annual Meeting of the Society of Biological Psychiatry. p 646.
104. Rosecrans J.A. Differences in brain area 5-hydroxytryptamine turnover and behaviour in rats: Strain and sex variability. Eur J Pharmacol. 9:1970;379-382.
105. Rubinow D.R. The premenstrual syndrome: New views. JAMA. 268:1992;1908-1912.
106. Rubinow D.R., Hoban M.C., Grover G.N., et al. Changes in plasma hormones across the menstrual cycle in patients with menstrually related mood disorder and in control subjects. Am J Obstet Gynecol. 158:1988;5-11.
107. 1A agonist, 8-OH-DPAT. Pharmacol Biochem Behav. 43:1992;953-955.
108. Schechter D, Strasser TJ, Endicott J, Petkova E, Nee J (1996): Role of ovarian steroids in modulating mood in premenstrual syndrome. In: Abstracts of the 51st Annual Meeting of the Society of Biological Psychiatry. p 646.
109. Schmidt P.J., Nieman L.K., Grover G.N., Muller K.L., Merriam G.R., Rubinow D.R. Lack of effect of induced menses on symptoms in women with premenstrual syndrome. N Engl J Med. 324:1991;1174-1179.
110. Schmidt PJ, Berman K, Leibenluft E, et al (1997): The neuroregulatory consequences of hypogonadism. In: Abstracts of the 79th Annual Meeting of the Endocrinological Society, p 55.
111. Schmidt P.J., Nieman L.K., Danaceau M.A., Adams L.F., Rubinow D.R. Differential behavioral effects of gonadal steroids in women with and in those without premenstrual syndrome. N Engl J Med. 338:1998;209-216.
112. Schrader W.T., O'Malley B.W. Progesterone-binding components of chick oviduct. J Biol Chem. 217:1972;51-59.
113. Sherwin B.B., Suranyi-Cadotte B.E. Up-regulatory effect of estrogen on platelet 3H-imipramine binding sites in surgically menopausal women. Biol Psychiatry. 28:1990;339-348.
114. Shughrue P.J., Komm B., Merchenthaler I. The distribution of estrogen receptor-β mRNA in the rat hypothalamus. Steroids. 61:1996;678-681.
115. Simerly R.B., Swanson L.W., Gorski R.A. Demonstration of a sexual dimorphism in the distribution of serotonin-immunoreactive fibers in the medial preoptic nucleus of the rat. J Comp Neurol. 225:1984;151-166.
116. Steiner M., Steinberg S., Stewart D., et al. Fluoxetine in the treatment of premenstrual syndrome. N Engl J Med. 332:1995;1529-1534.
117. Su T.-P., Schmidt P.J., Danaceau M., Murphy D.L., Rubinow D.R. Effect of menstrual cycle phase on neuroendocrine and behavioral responses to the serotonin agonist m-chlorophenylpiperazine in women with premenstrual syndrome and controls. J Clin Endocrinol Metab. 82:1997;1220-1228.
118. Su T.-P., Schmidt P.J., Danaceau M.A., et al. Fluoxetine in the treatment of premenstrual dysphoria. Neuropsychopharmacology. 16:1997;346-356.
119. Sumner B.E.H., Fink G. Effects of acute estradiol on 5-hydroxytryptamine and dopamine receptor subtype mRNA expression in female rat brain. Mol Cell Neurosci. 4:1993;83-92.
120. 2A receptors in cerebral cortex and nucleus accumbens in the female rat. J Steroid Biochem Mol Biol. 54:1995;15-20.
121. 1A receptor mRNA in female rat brain. Abstr Soc Neurosci. 23:1997;1501.
122. Toran-Allerand C.D. Developmental interactions of estrogens with the neurotrophins and their receptors. Micevych P., Hammer R.P. Neurobiological Effects of Sex Steroid Hormones. 1994;391-411 Cambridge University Press, Cambridge.
123. Uphouse L., Williams J., Eckols K., Sierra V. Cortical changes in serotonin receptors during the female rat estrous cycle. Brain Res. 381:1986;376-381.
124. 1A agonist 8-OH-DPAT. Pharmacol Biochem Behav. 40:1991;901-906.
125. Vaccari A., Brotman S., Cimino J., Timiras P.S. Sex differentiation of neurotransmitter enzymes in central and peripheral nervous systems. Brain Res. 132:1977;176-185.
126. Veeninga A.T., Westenberg H.G.M. Serotonergic function and late luteal phase dysphoric disorder. Psychopharmacology (Berl). 108:1992;153-158.
127. Vogel W., Klaiber E.L., Broverman D.M. Roles of the gonadal steroid hormones in psychiatric depression in men and women. Prog Neuropsychopharmacol. 2:1978;487-503.
128. Walsh A.E.S., Oldman A.D., Franklin M., Fairburn C.G., Cowen P.J. Dieting decreases plasma tryptophan and increases the prolactin response to d-fenfluramine in women but not men. J Affect Disord. 33:1995;89-97.
129. Wang M., Seippel L., Purdy R.H., Bäckström T. Relationship between symptom severity and steroid variation in women with premenstrual syndrome: Study on serum pregnenolone, pregnenolone sulfate, 5α-pregnane-3,20-dione and 3α-hydroxy-5α-pregnan-20-one. J Clin Endocrinol Metab. 81:1996;1076-1082.
130. Wang T.T.Y., Sathyamoorthy N., Phang J.M. Molecular effects of genistein on estrogen receptor mediated pathways. Carcinogenesis. 17:1996;271-275.
131. Werner A.A., Johns G.A., Hoctor E.F., Ault C.C., Kohler L.W., Weis M.W. Involutional melancholia: Probable etiology and treatment. JAMA. 103:1934;13-16.
132. West C.P., Hillier H. Ovarian suppression with the gonadotrophin-releasing hormone agonist goserelin (Zoladex) in management of the premenstrual tension syndrome. Hum Reprod. 9:1994;1058-1063.
133. Williams J., Uphouse L. Serotonin binding sites during proestrus and following estradiol treatment. Pharmacol Biochem Behav. 33:1989;615-620.
134. Wong M., Moss R.L. Long-term and short-term electrophysiological effects of estrogen on the synaptic properties of hippocampal CA1 neurons. J Neurosci. 12:1992;3217-3225.
135. Wurtman J.J. Carbohydrate craving: Relationships between carbohydrate intake and disorders of mood. Drugs. 39:1990;49-52.
136. Yatham L., Barry S., Dinan T.G. Serotonin in psychobiology of premenstrual syndrome. Lancet. i:1989;1447-1448.
137. Young S.N., Gauthier S., Anderson G.M., Purdy W.C. Tryptophan, 5-hydroxyindoleacetic acid and indoleacetic acid in human cerebrospinal fluid: Interrelationships and the influence of age, sex, epilepsy and anticonvulsant drugs. J Neurol Neurosurg Psychiatry. 43:1980;438-445.